Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Data on IPX066 APEX-PD Phase III Study for the Treatment of Early Parkinson’s Disease to be Presented at the American Academy of Neurology Conference
Data on IPX066 APEX-PD Phase III Study for the Treatment of Early Parkinson’s Disease to be Presented at the American Academy of Neurology Conference
Data on IPX066 APEX-PD Phase III Study for the Treatment of Early Parkinson’s Disease to be Presented at the American Academy of Neurology Conference
Submitted by
admin
on April 2, 2011 - 10:25am
Source:
Yahoo/BusinessWire
News Tags:
Impax
IPX066 APEX-PD
Parkinson's Disease
Headline:
Data on IPX066 APEX-PD Phase III Study for the Treatment of Early Parkinson’s Disease to be Presented at the American Academy of Neurology Conference
Do Not Allow Advertisers to Use My Personal information
